Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer

Hepatocellular carcinoma (HCC) and renal cell cancer (RCC) are malignancies, which are chemotherapy resistant and fatal at the advanced stages. Previously developed tyrosine kinase inhibitors are used in the treatment of advanced stage disease. In the present case study, a patient using sunitinib fo...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Clin Oncol
Main Authors: KUS, TULAY, AKTAS, GOKMEN, SEVINC, ALPER, OKTAY, CEMIL, KALENDER, MEHMET EMIN, CAMCI, CELALETDIN
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2016
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734193/
https://ncbi.nlm.nih.gov/pubmed/26893877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.677
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker